John Thornhill

An opinion piece arguing about AI’s potential to cure diseases, anchored by a personal AML story and Basecamp Research, but hampered by garbled text and a lack of actionable data or regulatory detail.

Anthropic's $65B round at a near-$1T post-money valuation underlines US AI funding dominance while Europe relies more on enabling enterprises, signaling divergent funding dynamics and competitive risk.

Sifted’s pro piece argues legal AI is shifting to “agentic law,” highlighting Legora’s $550m funding at a $5.6B valuation and contrasting specialist AI speed/cost with Anthropic.